{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:43:14Z","timestamp":1790739794735,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Natural sciences Foundation of China (NSFC)","award":["81050025"],"award-info":[{"award-number":["81050025"]}]},{"name":"Key Laboratory Foundation of Neurodegenerative Diseases of Ministry of Education (KLFNDME)","award":["2011SJBX02"],"award-info":[{"award-number":["2011SJBX02"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.neuropharm.2016.02.031","type":"journal-article","created":{"date-parts":[[2016,2,28]],"date-time":"2016-02-28T18:13:58Z","timestamp":1456683238000},"page":"587-593","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["5-(4-hydroxy-3-dimethoxybenzylidene)-rhodanine (RD-1)-improved mitochondrial function prevents anxiety- and depressive-like states induced by chronic corticosterone injections in mice"],"prefix":"10.1016","volume":"105","author":[{"given":"Nan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhili","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianfeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingping","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.neuropharm.2016.02.031_bib1","first-page":"298","article-title":"The effects of chronic antidepressant treatment in an animal model of anxiety","volume":"95","author":"Bodnoff","year":"1998","journal-title":"Psychopharmacol. Berl."},{"issue":"3","key":"10.1016\/j.neuropharm.2016.02.031_bib2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/syn.21622","article-title":"Mitochondrial plasticity of the hippocampus in a genetic rat model of depression after antidepressant treatment","volume":"67","author":"Chen","year":"2013","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2016.02.031_bib3","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.mcn.2007.08.004","article-title":"Serotonin stimulates mitochondrial transport in hippocampal neurons","volume":"36","author":"Chen","year":"2007","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2016.02.031_bib5","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.nbd.2012.06.015","article-title":"Mitochondrial trafficking in neuropsychiatric diseases","volume":"51","author":"Deheshi","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2016.02.031_bib6","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/nrm2275","article-title":"Functions and dysfunctions of mitochondrial dynamics","volume":"8","author":"Detmer","year":"2007","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"10.1016\/j.neuropharm.2016.02.031_bib7","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0006-3223(00)01020-9","article-title":"Neuroimaging studies of mood disorders","volume":"48","author":"Drevets","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2016.02.031_bib8","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0959-4388(00)00203-8","article-title":"Neuroimaging and neuropathological studies of depression: implications for the cognitive\u2013emotional features of mood disorders","volume":"11","author":"Drevets","year":"2001","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2016.02.031_bib9","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/sj.npp.1300433","article-title":"Effects of chronic fluoxetine in animal models of anxietyand depression","volume":"29","author":"Dulawa","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2016.02.031_bib10","first-page":"146","article-title":"Mechanisms of antidepressant resistance","volume":"4","author":"EI-Hage","year":"2013","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.02.031_bib11","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1176\/appi.ajp.2007.06122032","article-title":"Lateralized caudate metabolic abnormalities in adolescent major depressive disorder: a proton MR spectroscopy study","volume":"164","author":"Gabbay","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2016.02.031_bib12","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1038\/nprot.2006.476","article-title":"Imaging synaptic vesicle exocytosis and endocytosis with FM dyes","volume":"1","author":"Gaffield","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neuropharm.2016.02.031_bib13","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1017\/S1092852900013936","article-title":"Mitochondrial function is related to alterations at brain SPECT in depressed patients","volume":"13","author":"Gardner","year":"2008","journal-title":"CNS Spectr."},{"key":"10.1016\/j.neuropharm.2016.02.031_bib15","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1440-1819.2010.02178.x","article-title":"Connectivity between mitochondrial functions and psychiatric disorders","volume":"65","author":"Hroudova","year":"2011","journal-title":"Psychiatry Clin. Neurosci"},{"key":"10.1016\/j.neuropharm.2016.02.031_bib16","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.pscychresns.2011.07.006","article-title":"Hippocampal neurometabolite changes in depression treatment: a (1)H magnetic resonance spectroscopy study","volume":"201","author":"Husarova","year":"2012","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.neuropharm.2016.02.031_bib17","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bbr.2012.08.016","article-title":"Acute and sustained effects of a metabotropic glutamate 5 receptor antagonist in the novelty-suppressed feeding test","volume":"235","author":"Iijima","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2016.02.031_bib18","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1517\/14728210903107751","article-title":"Emerging drugs for major depressive disorder","volume":"14","author":"Kennedy","year":"2009","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.neuropharm.2016.02.031_bib19","doi-asserted-by":"crossref","first-page":"7212","DOI":"10.1523\/JNEUROSCI.0711-11.2011","article-title":"The Parkinsonian mimetic, MPP+, specifically impairs mitochondrial transport in dopamine axons","volume":"31","author":"Kim-Han","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2016.02.031_bib21","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3389\/fnins.2010.00192","article-title":"A\u00a0new strategy for antidepressant prescription","volume":"4","author":"Lavergne","year":"2010","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2016.02.031_bib22","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1091\/mbc.e07-05-0515","article-title":"The function of mitochondria in presynaptic development at the neuromuscular junction","volume":"19","author":"Lee","year":"2008","journal-title":"Mol. Biol. Cell."},{"key":"10.1016\/j.neuropharm.2016.02.031_bib23","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00213-009-1684-3","article-title":"Acute administration of leptin produces anxiolytic-like effects: a comparison with fluoxetine","volume":"207","author":"Liu","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2016.02.031_bib24","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.neuint.2011.02.019","article-title":"Dynamic proteomic analysis of protein expression profiles in whole brain of Balb\/c mice subjected to unpredictable chronic mild stress: implications for depressive disorders and future therapies","volume":"58","author":"Liu","year":"2011","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2016.02.031_bib25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jad.2006.07.017","article-title":"Cost-of-illness studies of depression: a systematic review","volume":"98","author":"Luppa","year":"2007","journal-title":"J.\u00a0Affect. Disord."},{"key":"10.1016\/j.neuropharm.2016.02.031_bib26","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1242\/jcs.01130","article-title":"Axonal mitochondrial transport and potential are correlated","volume":"117","author":"Miller","year":"2004","journal-title":"J.\u00a0Cell. Sci."},{"key":"10.1016\/j.neuropharm.2016.02.031_bib27","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.neuropharm.2015.01.030","article-title":"Neuroprotective effects of 5-(4-hydroxy-3-dimethoxybenzylidene)-thiazolidinone in MPTP induced Parkinsonism model in mice","volume":"93","author":"Ren","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2016.02.031_bib28","first-page":"55","article-title":"How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions","volume":"21","author":"Sapolsky","year":"2000","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.neuropharm.2016.02.031_bib30","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.3390\/ijms10052252","article-title":"Mitochondria and energetic depression in cell pathophysiology","volume":"10","author":"Seppet","year":"2009","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2016.02.031_bib33","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1590\/1516-4446-2013-1224","article-title":"Mitochondria and the central nervous system: searching for a pathophysiological basis of psychiatric disorders","volume":"36","author":"Streck","year":"2014","journal-title":"Rev. Bras. Qsiquiatr."},{"key":"10.1016\/j.neuropharm.2016.02.031_bib34","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.neuron.2005.06.018","article-title":"Synaptic mitochondria are critical for mobilization of reserve pool vesicles at Drosophila neuromuscular junctions","volume":"47","author":"Verstreken","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2016.02.031_bib35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1034\/j.1600-0447.2000.101001011.x","article-title":"PET measurements of brain glucose metabolism and blood flow in major depressive disorder: a critical review","volume":"101","author":"Videbech","year":"2000","journal-title":"Acta Psychiat. Scand"},{"key":"10.1016\/j.neuropharm.2016.02.031_bib36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.pbb.2012.03.013","article-title":"Long-term naringin consumption reverses a glucose uptake defect and improves cognitive deficits in a mouse model of Alzheimer's disease","volume":"102","author":"Wang","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2016.02.031_bib38","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(13)61611-6","article-title":"Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010","volume":"382","author":"Whiteford","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2016.02.031_bib39","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ejphar.2007.12.005","article-title":"A\u00a0mouse model of depression induced by repeated corticosterone injections","volume":"581","author":"Zhao","year":"2008","journal-title":"Eur. J. Pharmacol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390816300661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390816300661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T00:22:35Z","timestamp":1713399755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390816300661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":32,"alternative-id":["S0028390816300661"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2016.02.031","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"5-(4-hydroxy-3-dimethoxybenzylidene)-rhodanine (RD-1)-improved mitochondrial function prevents anxiety- and depressive-like states induced by chronic corticosterone injections in mice","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2016.02.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}